What are the benefits and risks of DAPT compared to single antiplatelet therapy within 5 y for prevention of recurrent stroke in patients with an ischemic stroke or TIA?
Dual antiplatelet therapy (DAPT) has been found to reduce the risk of recurrent stroke in patients with an ischemic stroke or TIA compared to single antiplatelet therapy. However, DAPT does have associated risks, such as an increased risk of bleeding. Therefore, it is important to discuss the potential benefits and risks of DAPT with your healthcare provider before starting it.